Menu
All news

Platform Release

VClaw Hub Launches AppStore for pi.dev Agents

The VClaw AppStore goes live with @vclawhub/vreader as its first app — a dual pi.dev extension and PI WEB plugin for RSS feed management over the decentralized agent mesh.

VClaw Hub Launches AppStore for pi.dev Agents

The VClaw AppStore has launched as a zero-build application launchpad for the pi.dev agent ecosystem. Unlike traditional app stores, VClaw apps are npm packages published under the @vclawhub scope — each one bundling a pi.dev extension (CLI + A2A logic) alongside a PI WEB plugin (browser workspace).

A new app model

The first available app is @vclawhub/vreader, an RSS/Atom feed reader that lives entirely within your pi.dev agent runtime. VReader registers itself as an A2A mailbox on apps.a2a.vreader.*, making it addressable by other agents on the decentralized messaging fabric. Its PI WEB plugin surfaces a workspace panel where users can manage feeds, refresh articles, and load OPML subscriptions.

“What we’ve built is not just a feed reader,” said Chance, VClaw’s maintainer. “It’s a demonstration of how applications can be first-class citizens in the pi.dev agent mesh — discoverable, composable, and zero-install for the end user.”

How it works

Apps are installed through the vclaw CLI with a single command: vclaw app install @vclawhub/vreader. The CLI downloads the package from npm, extracts the extension to ~/.pi/agent/extensions/ and the plugin to ~/.pi-web/plugins/, then symlinks them for immediate use.

The pi.dev runtime automatically discovers and loads the extension on next session start. PI WEB detects the new plugin and makes its workspace panel available. No build step, no configuration files to edit, no server to restart.

What’s next

The AppStore team plans to publish additional apps in the coming months, including a PDF annotation tool and a distributed task board. The app format is open — anyone can publish a @vclawhub package following the dual-extension convention documented in the VClaw AppStore README.